<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>449</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14722079</PubmedId>
            <Abstract>The binding of Factor IX to membranes during blood coagulation is mediated by the N-terminal gamma-carboxyglutamic acid-rich (Gla) domain, a membrane-anchoring domain found on vitamin K-dependent blood coagulation and regulatory proteins. Conformation-specific anti-Factor IX antibodies are directed at the calcium-stabilized Gla domain and interfere with Factor IX-membrane interaction. One such antibody, 10C12, recognizes the calcium-stabilized form of the Gla domain of Factor IX. We prepared the fully carboxylated Gla domain of Factor IX by solid phase peptide synthesis and crystallized Factor IX-(1-47) in complex with Fab fragments of the 10C12 antibody. The overall structure of the Gla domain in the Factor IX-(1-47)-antibody complex at 2.2 A is similar to the structure of the Factor IX Gla domain in the presence of calcium ions as determined by NMR spectroscopy (Freedman, S. J., Furie, B. C., Furie, B., and Baleja, J. D. (1995) Biochemistry 34, 12126-12137) and by x-ray crystallography (Shikamoto, Y., Morita, T., Fujimoto, Z., and Mizuno, H. (2003) J. Biol. Chem. 278, 24090-24094). The complex structure shows that the complementarity determining region loops of the 10C12 antibody form a hydrophobic pocket to accommodate the hydrophobic patch of the Gla domain consisting of Leu-6, Phe-9, and Val-10. Polar interactions also play an important role in the antibody-antigen recognition. Furthermore, the calcium coordination network of the Factor IX Gla domain is different than in Gla domain structures of other vitamin K-dependent proteins. We conclude that this antibody is directed at the membrane binding site in the omega loop of Factor IX and blocks Factor IX function by inhibiting its interaction with membranes.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>14338-46</ArticlePages>
            <ArticleTitle>Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Mingdong</ForeName>
                </Author>
                <Author>
                    <LastName>Furie</LastName>
                    <ForeName>Barbara C</ForeName>
                </Author>
                <Author>
                    <LastName>Furie</LastName>
                    <ForeName>Bruce</ForeName>
                </Author>
            </Authors>
            <ArticleChemicalList>Factor IX GLA-peptide;Immunoglobulin Fab Fragments;Peptide Fragments;Factor IX;Calcium</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antibody Specificity; Calcium(chemistry); Crystallography; Factor IX(chemistry; immunology; metabolism); Humans; Immunoglobulin Fab Fragments(chemistry; immunology; metabolism); Molecular Sequence Data; Peptide Fragments(chemistry; immunology; metabolism); Protein Binding(immunology); Protein Structure, Tertiary</ArticleMeshHeadingsList>
            <Journal>
                <Volume>279</Volume>
                <Issue>14</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>mAb 10C12 epitope of factor IX Gla domain</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>K51, L52, E54, F55, V56, Q57</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P00740.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>77263</EpitopeId>
                <ReferenceRegion>K5, L6, E8, F9, V10, Q11</ReferenceRegion>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1 to 4, Table II</LocationOfData>
                        <BCellId>2211</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Antibody 10C12 was one of a panel antibodies identified from phage display single-chain Fv human antibody library screened against a synthetic Factor IX Gla domain in the presence of calcium ion. It was then reformatted into a F(ab')2-like form with two Fab fragments connected by a leucine zipper, and the free Fab fragments were obtained by papain digestion.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.2</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>Antibody is directed at the membrane binding site in the omega-loop of Factor IX and blocks factor IX function by inhibiting its interaction with membrane.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>10C12</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>10C12</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>3D69_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>3D69_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Coagulation factor IX precursor Gla domain</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YNSGKLEEFVQGNLERECMEEKCSFEEAREVFENTERTTEFWKQY</LinearSequence>
                                        <StartingPosition>47</StartingPosition>
                                        <EndingPosition>91</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P00740.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1NL0</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>G</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Six calcium ions are required for the folding of Gla domains into functional membrane binding structures. Three ions coordinate Fab-Gla interaction by G:E8. The bound 10C12 antibody does not appear to perturb the structure of Factor IX-(1-47) (free factor IX [PDB: 1J34, 1J35], specifically at the antibody binding site.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>G: K5, L6, (CGU)8, F9, V10, Q11</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T31:H1, S52:H2, Y52A:H2, K56:H2, K57:H2, Y58:H2, A98:H3; L: N31:L1, W91:L3, D93:L3;</AntibodyResiduesInteractingWithAntigen>
                                <InteractingAtomPairs>&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;dataroot xmlns:od="urn:schemas-microsoft-com:officedata" generated="2005-04-18T12:23:19"&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;1&lt;/AtomPairID&gt;
&lt;BindingID&gt;46&lt;/BindingID&gt;
&lt;PDB_ID&gt;1nl0&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;G&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;F (Phe)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;9&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;O&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;H&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;52A&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;N&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;2&lt;/AtomPairID&gt;
&lt;BindingID&gt;46&lt;/BindingID&gt;
&lt;PDB_ID&gt;1nl0&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;G&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;Q (Gln)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;11&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NE2&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;H&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;T (Thr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;31&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OG1&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;3&lt;/AtomPairID&gt;
&lt;BindingID&gt;46&lt;/BindingID&gt;
&lt;PDB_ID&gt;1nl0&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;G&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;K (Lys)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;5&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NZ&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;D (Asp)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;93&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OD1&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;4&lt;/AtomPairID&gt;
&lt;BindingID&gt;46&lt;/BindingID&gt;
&lt;PDB_ID&gt;1nl0&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;G&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;K (Lys)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;5&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NZ&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;N (Asn)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;31&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OD1&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;/dataroot&gt;</InteractingAtomPairs>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>G: K5, L6, (CGU)8, F9, V10, Q11</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T31, A33, I50, I51, S52, Y52A, K56, K57, Y58, S96, I97, A98, A99, A100; L: N30, N31, W91, D93</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>638.2</ContactAreaForAntigen>
                                <ContactAreaForAntibody>474.6</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

